New research reveals bone marrow-derived cells infiltrate the human brain with age, challenging decades of assumptions about microglia origins and suggesting protective effects against Alzheimer's.
By Adam Makins · 
For decades, neuroscientists believed microglia, the brain’s resident immune cells, were established early in life and maintained independently. A groundbreaking study published in Nature completely upends this assumption, revealing that bone marrow-derived cells continuously infiltrate the human brain throughout aging, fundamentally reshaping our understanding of how the brain’s immune system works.
Researchers at Stanford University developed an elegant approach to track cellular origins using somatic mutations as natural barcodes. Every cell accumulates unique mutations over time, creating a genetic fingerprint that identifies which clone of cells a particular microglia belongs to. By analyzing brain tissue from 20 aged individuals, scientists discovered compelling evidence that marrow-derived cells steadily infiltrate the brain in all examined subjects.
This method represents a significant breakthrough in science. Rather than relying on traditional markers that can be ambiguous, the researchers essentially let cells record their own history through accumulated genetic changes. Think of it like reading the growth rings of a tree to understand its life story.
The findings are striking. Single cell analysis combined with mitochondrial DNA lineage tracing demonstrated that infiltrating cells behave remarkably like microglia and can comprise a substantial fraction of the microglial pool in older adults. This means that a significant portion of the brain’s immune system isn’t actually derived from embryonic sources as previously believed, but rather migrates from bone marrow throughout life.
The study analyzed 20 aged individuals, tracking how many of their brain immune cells originated from marrow versus embryonic sources. In every single person examined, evidence of this infiltration was present. The consistency across all subjects suggests this isn’t an anomaly but rather a fundamental biological process.
Perhaps most intriguingly, the research found a protective association between clonal hematopoiesis and Alzheimer’s disease. Clonal hematopoiesis refers to the expansion of specific blood cell clones, and most types showed protective effects. This unexpected finding opens new avenues for understanding neurodegenerative diseases and raises questions about why these cells might shield the brain from cognitive decline.
If bone marrow cells infiltrating the brain can provide protection against Alzheimer’s, understanding their mechanisms could lead to novel therapeutic approaches. Researchers might eventually harness these protective qualities to develop treatments that bolster the brain’s natural defenses.
This work contradicts the long-held dogma that human microglia, like their mouse counterparts, are established during embryonic development and maintained largely independently from adult blood production. Mouse studies suggested minimal adult hematopoietic contribution. Yet humans, with their longer lifespans and different biology, appear to follow a different playbook.
The discovery highlights an important principle in science: animal models don’t always translate directly to human biology. While mice maintain microglia through local self-renewal, humans apparently benefit from a continuous supply of fresh immune cells from bone marrow. This difference likely reflects our extended lifespan and the accumulated wear on brain immune systems over decades.
The implications extend beyond basic biology. Understanding that the brain’s immune system remains dynamic throughout life changes how researchers think about age-related brain diseases. Rather than viewing microglia solely as a fixed population established before birth, scientists now recognize them as part of an ongoing cellular ecosystem shaped by both local maintenance and systemic recruitment.
The protective association with clonal hematopoiesis particularly warrants attention. If certain blood cell clones provide neurological benefits, identifying what makes them special could unlock new preventive or therapeutic strategies for aging-related cognitive decline.
This research demonstrates how technological innovation, creative thinking, and careful human-centered biology can overturn established assumptions. The next chapter will likely explore whether we can therapeutically amplify these protective mechanisms and potentially slow cognitive aging.
Source: Nature (2026)
